Kalaris Therapeutics Inc

NASDAQ: KLRS · Real-Time Price · USD
2.46
0.19 (8.37%)
At close: Aug 15, 2025, 3:55 PM
2.42
-1.43%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kalaris Therapeutics Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022
Period Ending Dec 31, 2023 Dec 31, 2022
Cash & Equivalents
3.17M 3.06M
Short-Term Investments
n/a n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
n/a n/a
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
n/a n/a
Total Current Assets
3.33M 3.9M
Property-Plant & Equipment
n/a n/a
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
n/a n/a
Total Assets
3.33M 3.9M
Account Payables
2.36M 2.76M
Deferred Revenue
n/a n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
540K 296K
Total Current Liabilities
3.94M 5.69M
Long-Term Debt
n/a 3.25M
Other Long-Term Liabilities
44.41M 25.23M
Total Long-Term Liabilities
44.41M 28.48M
Total Liabilities
48.35M 34.17M
Total Debt
n/a 3.25M
Common Stock
n/a n/a
Retained Earnings
-47.39M -32.7M
Comprehensive Income
n/a n/a
Shareholders Equity
-45.02M -30.27M
Total Investments
n/a n/a